Characterisation of immune responses in pancreatic carcinoma patients after mutant p21 ras peptide vaccination.

por Gjertsen, M. K., Saeterdal, I., Thorsby, E., Gaudernack, G.
Publicado 1996

Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study

por Bernhardt, S L, Gjertsen, M K, Trachsel, S, Møller, M, Eriksen, J A, Meo, M, Buanes, T, Gaudernack, G
Publicado 2006